Budget Impact Model of Sunitinib as First Line Treatment of Metastatic Renal Cell Carcinoma in China
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.099
https://www.valueinhealthjournal.com/article/S1098-3015(14)02029-4/fulltext
Title :
Budget Impact Model of Sunitinib as First Line Treatment of Metastatic Renal Cell Carcinoma in China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02029-4&doi=10.1016/j.jval.2014.08.099
First page :
A734
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2104